Skip to main content

depo-subQ provera 104 Pfizer Inc. - Treatment for Prevention of Pregnancy

depo-subQ provera 104 (104 mg/0.65 mL) is a lower dose, subcutaneous formulation of Depo Provera indicated for the prevention of pregnancy in women of child bearing potential.

depo-subQ provera 104 (medroxyprogesterone acetate) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.